Rosen to Rep Biogen Investors In Drug Trial Fraud Suit
The Rosen Law Firm will represent a proposed class of investors in a suit alleging Biogen Inc. and three of its executives misrepresented the odds of approval for one of the...To view the full article, register now.
Already a subscriber? Click here to view full article